USFDA completes audit at Jubilant HollisterStier 2 Washington facilities

Written By :  Ruchika Sharma
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2024-09-26 05:00 GMT   |   Update On 2024-09-26 05:00 GMT
Advertisement

Noida: Jubilant Pharmova Limited has announced that the United States Food and Drug Administration (USFDA) has concluded an audit of the Jubilant HollisterStier LLC’s Allergy immunotherapy facility and Contract manufacturing facility, both located in Spokane, Washington (USA) from September 18 to 25, 2024.

The inspection concluded with no observations. Jubilant HollisterStier LLC is a subsidiary of Jubilant Pharma Holding Inc., USA, which is a subsidiary of Jubilant Pharma Limited, Singapore, a wholly owned subsidiary of the company.
Advertisement
Jubilant HollisterStier LLC, based out of Spokane-Washington (USA) is a fully integrated contract manufacturing organization along with leading Allergy Immunotherapy provider in North America. The CMO business offers manufacturing services including sterile injectables (both liquid and lyophilization), ampoules and ophthalmics (Ointment, liquid and creams). With facilities in North America, Jubilant HollisterStier provides specialized manufacturing for the pharmaceutical and biopharmaceutical industries. The services include a full-range of support to streamline the manufacturing processes, from process qualifications through commercial release.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News